Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts

Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications

(2016) Aixiu Qiao et al.   Frontiers of Medicine

Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go

(2016) Rachel Buchsbaum et al.   Cancers

Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer

(2015) Sung Yeon Park et al.   BREAST CANCER RESEARCH AND TREATMENT

Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling

(2015) X Tang et al.   CELL DEATH AND DIFFERENTIATION

Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment

(2015) H Tian et al.   ONCOGENE

MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer

(2014) Jae Moon Gwak et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis

(2014) Weiying Zhou et al.   CANCER CELL

Absence of feedback regulation in the synthesis of COL1A1

(2014) Kevin Dzobo et al.   LIFE SCIENCES

Functional subsets of mesenchymal cell types in the tumor microenvironment

(2014) Eliane Cortez et al.   SEMINARS IN CANCER BIOLOGY

Biological Characteristics and Genetic Heterogeneity between Carcinoma-Associated Fibroblasts and Their Paired Normal Fibroblasts in Human Breast Cancer

(2013) Qiongle Peng et al.   PLoS One

Triple-negative breast cancer: epidemiological considerations and recommendations

(2012) P. Boyle   ANNALS OF ONCOLOGY

Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway

(2012) Guanglei Zhuang et al.   EMBO JOURNAL

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

(2012) Marilena V. Iorio et al.   EMBO Molecular Medicine

MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer

(2012) Liuyang Zhao et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness

(2012) Cristiana Angelucci et al.   PLoS One

MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer

(2012) A. K. Mitra et al.   Cancer Discovery

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Frozen robust multiarray analysis (fRMA)

(2010) M. N. McCall et al.   BIOSTATISTICS

The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts

(2010) Olga Aprelikova et al.   CELL CYCLE

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

(2010) Li Ma et al.   NATURE CELL BIOLOGY

Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast

(2010) M Bauer et al.   ONCOGENE

Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy

(2009) Alex Y. Strongin   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts

(2009) Patricia Bortman Rozenchan et al.   INTERNATIONAL JOURNAL OF CANCER

lumi: a pipeline for processing Illumina microarray

(2008) P. Du et al.   BIOINFORMATICS

Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer

(2008) Theresa Casey et al.   BREAST CANCER RESEARCH AND TREATMENT

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

(2008) Ariane Sadr-Nabavi et al.   INTERNATIONAL JOURNAL OF CANCER

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE